Lysergic acid diethylamide (LSD)
Overview of LSD: its effects, history, pharmacology, therapeutic research, risks, legal status, and cultural significance in plain, neutral terms.
Lysergic acid diethylamide, commonly abbreviated LSD and often called "acid," is a synthetic psychoactive compound best known for producing profound alterations in perception, mood, and thought. Chemically derived from lysergic acid, a component of ergot fungi, LSD is one of the most potent classical psychedelics. Its effects vary by dose, individual sensitivity, and contextual factors such as mindset and environment.
Image gallery
10 ImagesCharacteristics and acute effects
LSD is active at very low doses and typically taken orally. Acute effects commonly include visual and auditory distortions, altered sense of time, intensified emotions, and unusual thought patterns. Sensory changes may range from mild enhancements to intense hallucinations. Physiological responses can include pupil dilation, elevated heart rate, and changes in body temperature. Reactions are highly variable: the same dose may produce a wide spectrum of experiences among different people.
Mechanism and classification
At the neurochemical level, LSD primarily influences serotonin receptors in the brain, notably the 5-HT2A receptor, which is thought to play a key role in generating its characteristic perceptual and cognitive effects. Because of these actions, LSD is classified as a classic psychedelic alongside substances such as psilocybin and mescaline. For basic chemical and classification references see chemical data and psychedelic classification.
History and cultural impact
LSD was first synthesized in the 20th century and became widely studied and used during the mid-1900s. Researchers explored its potential as a tool in psychiatry and psychology, while later it gained prominence in popular culture and prompted legal restrictions in many countries. The compound has had lasting effects on art, music, and intellectual movements, influencing creative practices and public debates about consciousness and drug policy.
Medical research and therapeutic interest
Although most jurisdictions currently classify LSD as a controlled substance and routine medical use is limited, interest in clinical applications has re-emerged. Contemporary research investigates LSD-assisted psychotherapy for conditions such as anxiety related to terminal illness, treatment-resistant depression, and substance-use disorders. These investigations are experimental and typically conducted under regulated clinical protocols; for summaries of ongoing studies see clinical trial resources.
Risks, safety considerations, and legal status
Acute psychological risks include anxiety, panic, and temporarily disorganised thinking. In some individuals, particularly those with predispositions to psychotic disorders, psychedelics may precipitate lasting adverse effects. A small proportion of users report persistent perceptual changes after use. The context of use—"set" (mindset) and "setting" (environment)—strongly influences outcomes. Legally, LSD is restricted in many countries; possession and distribution are often subject to criminal penalties and it is generally categorized as having a high potential for misuse and limited accepted medical use.
Distinctions and current debates
- Distinguished from dissociative and stimulant drugs by its primary action on serotonergic systems and its characteristic perceptual alterations.
- Debate continues about potential therapeutic benefits versus risks, and about best practices for safe research and clinical use.
- Informal practices such as microdosing have attracted popular attention but remain a subject of scientific evaluation rather than established clinical recommendation.
For readers seeking more detailed chemical, legal, or clinical data, consult specialized pharmacology texts, institutional treatment guidelines, and peer-reviewed research summaries provided by authoritative sources.
Discovery
The chemist Albert Hofmann produced lysergic acid diethylamide (LSD) for the first time on 16 November 1938 as part of his research into ergot. His aim was to develop a circulatory stimulant. After this hoped-for effect of LSD did not occur in animal experiments, Hofmann initially lost interest and archived his research results. On April 16, 1943, he began testing LSD effects again, suspecting he had missed something. In the course of his work, he noticed in himself a hallucinogenic effect that he could not initially explain. Thus he suspected that he had absorbed the LSD through his skin by working uncleanly.
Hofmann repeated this experience on 19 April 1943 by taking 250 micrograms of LSD. Compared with the efficacy of the ergot alkaloids known at that time, this corresponded to the smallest amount at which one could still have expected an effect. However, it turned out that this amount already corresponded to ten times the normally effective dose (from about 20 µg) of lysergic acid diethylamide. This date is now considered the time of the discovery of the psychoactive properties of LSD. The anniversary is celebrated by pop-cultural LSD devotees as "Bicycle Day", since Hofmann rode home on a bicycle at the beginning of his consciously induced intoxication experience.
The Sandoz company, which commissioned Hofmann's research, marketed the preparation under the name "Delysid" in 1949. It was offered as a psychotomimetic that enabled psychiatric physicians to put themselves into the perceptual world of psychotic patients for a limited time.
Chemistry and analytics
Chemically, lysergic acid diethylamide belongs to the structural class of ergolines. The name "LSD-25" comes from the fact that it was the 25th substance in Hofmann's series of experiments on synthetic lysergic acid derivatives.
LSD is a chiral compound with two stereocenters at carbon atoms C-5 and C-8. Thus, four different stereoisomers of LSD exist, forming two pairs of enantiomers. LSD, more specifically (+)-LSD, has the absolute configuration (5R,8R). (-)-LSD is (5S,8S)-configured and is the mirror image of (+)-LSD. (+)-LSD epimerizes under basic conditions to the isomer (+)-iso-LSD with (5R,8S) configuration; (-)-LSD epimerizes basic to (-)-iso-LSD with (5S,8R) configuration. The non-psychoactive (+)-iso-LSD formed during synthesis (in varying proportions depending on the method) can be separated by chromatographic separation methods and isomerized (such as by the action of dilute methanolic potassium hydroxide solution) to active (+)-LSD. Several structural analogues of LSD are known which have the LSD or ergoline backbone as the lead structure, e.g. ALD-52, 1B-LSD, 1P-LSD, 1CP-LSD, AL-LAD, ETH-LAD, 1P-ETH-LAD and PRO-LAD. In this regard, modifications were made to the ergoline system at position 1 and position 6.
Under ultraviolet light (360 nm) LSD shows a strong blue fluorescence. With dimethylaminobenzaldehyde (Ehrlich reagent, Kovacs reagent) further detection is possible. The forensically reliable detection of LSD in various test materials such as hair or urine is possible after adequate sample preparation by coupling chromatographic methods with mass spectrometry. Since LSD is so potent, there is no need to contaminate or stretch the substance. In laboratories, the drug is rarely present as a powder, so purity is rarely measured.
Questions and answers
Q: What is LSD?
A: LSD is a psychedelic drug that alters thought processes and causes people who take it to witness illusions.
Q: What is the chemical name for LSD?
A: The chemical name for LSD is lysergic acid diethylamide.
Q: What is the slang name for LSD?
A: The slang name for LSD is acid.
Q: Has LSD been investigated as an adjunct to psychiatric therapies?
A: Yes, LSD has been investigated as an adjunct to psychiatric therapies for disorders such as alcoholism.
Q: What is the current use of LSD in medicine?
A: Currently, LSD is being investigated as a clinical tool for treating people with anxiety and depression associated with having a terminal illness.
Q: Is LSD currently recognized for medical use?
A: No, since there is no recognized medical use for LSD, its use in medicine is experimental.
Q: Is LSD legal to use?
A: The vast majority of LSD use is illegal and thus considered "drug abuse" according to some definitions.
Related articles
Author
AlegsaOnline.com Lysergic acid diethylamide (LSD) Leandro Alegsa
URL: https://en.alegsaonline.com/art/60156
Sources
- dx.doi.org : "LSD helps to treat alcoholism"
- doi.org : 10.1038/nature.2012.10200
- worldcat.org : 1744-7933
- timothyleary.us : timothyleary.us/

